Variant report
Variant | nsv521403 |
---|---|
Chromosome Location | chr6:102114780-102116069 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9485528 | chr6:102114780-102114781 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs376970237 | chr6:102114859-102114860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576399910 | chr6:102114918-102114919 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543717255 | chr6:102114953-102114954 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs145235070 | chr6:102114973-102114974 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533421253 | chr6:102114982-102114983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs151020917 | chr6:102115032-102115033 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140861746 | chr6:102115051-102115052 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149667743 | chr6:102115052-102115053 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185431794 | chr6:102115068-102115069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545774895 | chr6:102115087-102115088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545107321 | chr6:102115100-102115101 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376264693 | chr6:102115103-102115104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189203167 | chr6:102115184-102115185 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548753113 | chr6:102115195-102115196 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567544588 | chr6:102115199-102115200 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192861177 | chr6:102115207-102115208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs546369650 | chr6:102115226-102115227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141699008 | chr6:102115299-102115300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571131065 | chr6:102115303-102115304 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539513789 | chr6:102115318-102115319 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558241418 | chr6:102115325-102115326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569904293 | chr6:102115440-102115441 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375168864 | chr6:102115445-102115446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537449380 | chr6:102115469-102115470 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555517367 | chr6:102115524-102115525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145446428 | chr6:102115591-102115592 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541772351 | chr6:102115595-102115596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553573588 | chr6:102115616-102115617 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140226051 | chr6:102115685-102115686 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs145375019 | chr6:102115698-102115699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185473884 | chr6:102115719-102115720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575289658 | chr6:102115726-102115727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542594957 | chr6:102115742-102115743 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188646335 | chr6:102115769-102115770 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181121334 | chr6:102115799-102115800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369218473 | chr6:102115810-102115811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546506729 | chr6:102115818-102115819 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs17062280 | chr6:102115820-102115821 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140685500 | chr6:102115822-102115823 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532606256 | chr6:102115835-102115836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543481819 | chr6:102115839-102115840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550549186 | chr6:102115925-102115926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143740527 | chr6:102115981-102115982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537182400 | chr6:102116009-102116010 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7739084 | chr6:102116069-102116070 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21785460 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Obesity | 21045960 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Autism | 22543975 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:102113600-102114800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr6:102113600-102117000 | Enhancers | HMEC | breast |
3 | chr6:102113600-102117600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr6:102113800-102114800 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr6:102113800-102114800 | Enhancers | NH-A | brain |
6 | chr6:102114000-102114800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr6:102114000-102114800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
8 | chr6:102114000-102114800 | Enhancers | Hela-S3 | cervix |
9 | chr6:102114000-102116800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr6:102114000-102117000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr6:102114000-102117000 | Enhancers | NHEK | skin |
12 | chr6:102114600-102121600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr6:102114800-102116000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
14 | chr6:102114800-102116200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
15 | chr6:102116000-102116800 | Enhancers | Muscle Satellite Cultured Cells | -- |